Dr. Michelle Sands's bioidentical hormone claims checked

What does this Instagram post actually claim?

Dr. Michelle Sands, who positions herself as a menopause hormone expert, tells her 27,700 viewers that topical bioidentical hormones are superior to oral hormones and pellets. She lists three delivery methods but cuts off mid-sentence while explaining why she "always" recommends topical forms for her clients.

The post suggests topical hormones are more effective because they're "absorbed through the skin," though the caption gets truncated. This kind of absolute recommendation without nuance is exactly what makes hormone therapy discussions on social media problematic.

Are topical hormones actually superior?

The answer depends entirely on which hormone we're talking about and what outcomes you care about. For estradiol, topical forms do have some advantages. The ESTHER study (Canonico et al., BMJ 2007) found that transdermal estrogen carried lower venous thromboembolism risk compared to oral estrogen in 80,391 postmenopausal women.

But calling topical hormones universally "best" ignores real trade-offs. Oral estradiol produces higher estrone levels, which some women need. Pellets provide steady hormone levels for 3-4 months, eliminating daily compliance issues that plague topical users.

The Women's Health Initiative follow-up data shows oral conjugated equine estrogens plus progestin increased breast cancer risk by 26% over 5.6 years, but this doesn't automatically make bioidentical topical hormones safer long-term.

What's misleading about this approach?

Sands presents hormone delivery as a one-size-fits-all decision when individualization matters more than her preferences. Some women can't absorb topical hormones effectively due to skin thickness variations. Others develop contact dermatitis from gels and creams.

The "bioidentical" framing is also misleading. FDA-approved estradiol patches and gels are bioidentical to human hormones, but so are many oral forms. The term doesn't automatically mean safer or more natural.

Her absolute stance ("I always recommend topical") ignores that hormone therapy requires balancing multiple factors: absorption rates, convenience, cost, insurance coverage, and individual response patterns.

What should women actually know about hormone delivery?

Each delivery method has legitimate uses based on individual circumstances. Transdermal estrogen does avoid first-pass liver metabolism, potentially reducing clotting risks. The KEEPS trial (Harman et al., Menopause 2014) found similar symptom relief between oral and transdermal estrogen over 4 years in 727 recently menopausal women.

But absorption varies wildly between individuals. Some women need higher topical doses to achieve the same blood levels others get from lower oral doses. Pellets provide the most consistent levels but require minor surgical procedures every few months.

The real question isn't which delivery method is "best" but which works for your specific situation, symptoms, and risk factors. That requires actual medical evaluation, not Instagram advice.